RFS
OREX

Rockefeller Financial Services’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Rockefeller Financial Services’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,985
Closed -$123K – 651
2014
Q2 		$123K Hold
1,985
– – ﹤0.01% 368
2014
Q1 		$129K Sell
1,985
-195
-9% -$13.2K ﹤0.01% 376
2013
Q4 		$123K Buy
2,180
+202
+10% +$11.4K ﹤0.01% 381
2013
Q3 		$121K Buy
1,978
+227
+13% +$15.4K ﹤0.01% 377
2013
Q2 		$102K Buy
+1,751
New +$108K ﹤0.01% 387

Other funds holding OREX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Rockefeller Financial Services's OREX Position: Q3 2014 in Review

Rockefeller Financial Services sold out of Orexigen Therapeutics, Inc. (OREX) in Q3 2014, closing a stake of 1,985 shares — an estimated $123K sold.

Rockefeller Financial Services first reported a position in OREX in Q2 2013 and held it in 5 quarters. The position peaked at $129K in Q1 2014. 128 funds tracked by Wall St. Rank hold OREX as of Q3 2014.

  • Rockefeller Financial Services reported no remaining Orexigen Therapeutics, Inc. position as of Q3 2014 after selling out during the quarter.
  • Rockefeller Financial Services sold 1,985 Orexigen Therapeutics, Inc. shares in Q3 2014, an estimated $123K.
  • Rockefeller Financial Services first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 5 quarters.
  • Rockefeller Financial Services's Orexigen Therapeutics, Inc. position peaked at $129K in Q1 2014.
  • 128 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q3 2014.

Based on Rockefeller Financial Services's 13F filing for Q3 2014, filed 5 Nov 2014.